Logotype for Integral Diagnostics Limited

Integral Diagnostics (IDX) AGM 2026 summary

Event summary combining transcript, slides, and related documents.

Logotype for Integral Diagnostics Limited

AGM 2026 summary

29 Oct, 2026

Opening remarks and agenda

  • AGM opened at 10:00 a.m. after quorum confirmation; held in person and virtually, with poll voting on all resolutions.

  • Agenda covered Chair and CEO addresses, formal resolutions, shareholder questions and voting; FY26 financial report was presented for consideration.

  • First AGM as Managing Director and CEO, after just under three months in the role; outlined initial observations, actions underway, Q1 trading and FY27 outlook.

Financial performance review

  • FY26 revenue rose 25.6% to AUD 788.7m, operating EBITDA rose 30.3% to AUD 164.8m, and operating EBITDA margin expanded 80 bps to 20.9%.

  • FY26 operating NPAT increased 50.2% to AUD 47.4m; statutory NPAT was AUD 22.0m; operating diluted EPS rose 23.6% to AUD 0.126. Capitol Health merger synergies exceeded AUD 14m.

  • Net debt was AUD 298.9m and pre-AASB 16 net debt/EBITDA was 2.3x at 30 June 2026, versus 2.6x a year earlier.

  • Q1 FY27 revenue grew 3.0%, or 4.4% excluding closed sites and on a constant-currency basis; FY27 revenue growth guidance is 4%-6%.

  • FY27 operating EBITDA margin guidance is 19.5%-20.5%, with improvement expected in H2; capex guidance is AUD 50m-AUD 60m.

Board and executive committee updates

  • Jason Martinez became Managing Director and CEO in August 2026; Jenny Martin joined as CFO in October after becoming available earlier than expected.

  • Craig White retired as CFO after FY26 results; a new General Manager for Victoria, appointed in September 2026, brought more than 25 years of industry experience.

  • Chair credited succession planning and thorough handovers with supporting leadership continuity; Ian Kadish was acknowledged for eight years of leadership, including scaling the business and completing the Capitol Health merger.

  • Raelene Murphy resigned as Audit Committee Chair in March after nine years on the board; Laura McBain took over the role.

  • Toby Hall and Ingrid Player stood for re-election as directors.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Integral Diagnostics